Category: Latest News

Nano Nuclear Energy (NASDAQ:NNE) said its engineering collaboration with Howden, a Baker Hughes business, has progressed to the detailed design phase for the primary helium circulator of its KRONOS MMR™ Energy System. The helium circulator is a mechanical subsystem designed to move helium coolant through the reactor core to transfer heat. Howden is leading the…

Kala Bio, Inc. (NASDAQ:KALA) and Virotek Inc. have finalised an exclusive distribution and reseller agreement covering Virotek’s ophthalmology genomic testing and screening programme in the United States. Under the agreement, which took effect on September 4, 2026, Kala will serve as the sole U.S. distributor of the programme and will have the right to market,…

Advasa Holdings Inc (NASDAQ:ADBT) shares fell 11.6% in premarket trading on Thursday following the resignation of Chief Financial Officer Katharyn Field. According to an 8-K filing with securities regulators, Field formally resigned from her position on August 27, 2026. The company said Field’s departure was for personal reasons and was not related to any dispute…

Envista Holdings Corp. (NYSE:NVST) shares rose 2.3% in premarket trading on Thursday after JPMorgan upgraded the dental products company ahead of its September 17 Investor Day. JPMorgan analyst Lilia-Celine B Lozada raised Envista to Overweight from Neutral and increased the price target to $32 from $29. “Heading into Envista’s September 17th Investor Day, we are…

Ciena Corporation (NYSE:CIEN) shares rose 4.3% in premarket trading after the optical networking equipment company reported fiscal third-quarter earnings and revenue above analyst expectations. For the quarter ended August 1, 2026, Ciena reported adjusted earnings per share of $2.11, exceeding the analyst consensus of $1.72 by $0.39. Revenue increased 37% year over year to $1.67…

Climb Bio, Inc. (NASDAQ:CLYM) shares rose 17% on Thursday after the clinical-stage biotechnology company released Phase 1 trial data for CLYM116, its anti-APRIL monoclonal antibody being developed for IgA nephropathy. The company reported that a single 320 mg dose of CLYM116 resulted in near-complete APRIL suppression and 60% to 75% suppression of IgA/Gd-IgA1 through 12…

John Wiley & Sons, Inc. (NYSE:WLY) shares fell 3.5% after the company reported first-quarter revenue and adjusted earnings below analyst expectations while reaffirming its fiscal 2027 earnings guidance. Adjusted earnings per share were $0.44, compared with the consensus estimate of $0.46. Revenue declined 3% year over year to $386 million from $397 million and was…

Polestar Automotive (NASDAQ:PSNY) shares fell 8.3% after the electric vehicle manufacturer reported second-quarter revenue below analyst expectations and lowered its 2026 volume growth guidance. Revenue for the quarter was $727 million, compared with the Bloomberg Consensus estimate of $864.7 million. The company’s net loss narrowed to $459 million from $1.03 billion in the same period…